Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
Merck said on Monday it will split its human-health business into two divisions, separating its blockbuster cancer franchise led by Keytruda from its non-oncology medicines.
The shake-up comes as the drugmaker braces for the looming loss of ex… [531 chars]
Source: CNBC | Published: 2026-02-23T11:58:45Z
Credit: CNBC
